#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Cataract Retinopathy of prematurity Extraskeletal ossification Demyelination Hypochondroplasia CDKL5 deficiency disorder Vascular malformation Craniopharyngioma Alexander disease Hepatic angiosarcoma Peripheral primitive neuroectodermal tumour of soft tissue Insulinoma Metastases to peritoneum Selective polysaccharide antibody deficiency Biliary neoplasm More trials…

    Learn about Rare Diseases

    Hereditary motor and sensory neuropathy – Diagnostics Haemophilia A without inhibitors – Trials in Disease Alexander disease – Treatment Cytokine release syndrome – Diagnostics Progressive multifocal leukoencephalopathy – Trials in Disease Pulmonary fibrosis – Treatment Pulmonary fibrosis – Life with Disease Atypical haemolytic uraemic syndrome – Trials in Disease Rosai-Dorfman syndrome Myxofibrosarcoma More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    ADCE-D01 Lorlatinib Tiaprofenic Acid Dimeticone Quizartinib Dihydrochloride Cobolimab LY3841136 SODIUM L-Tryptophan Perampanel Rezvilutamide Levamlodipine Succinate Bhv-7000 Levomethadone Hydrochloride Rimegepant GRNA1599 Anidulafungin Incb099280 Atorvastatin Ferrous Sulfate VHB937 More therapies…

    Learn about Your Condition

    Ependymoma Aplastic anaemia Peripheral ischaemia Polymyositis Small intestine adenocarcinoma Arrhythmia supraventricular Systemic infection Dementia Alzheimer's type Obsessive-compulsive disorder Retinal neovascularisation Intracranial calcification Plasma cell myeloma recurrent Cervix carcinoma stage I Patent ductus arteriosus Gingival bleeding More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Hemic and Lymphatic Diseases

  • Study on the Effects and Safety of Emicizumab for Infants with Hemophilia A (Ages Birth to 12 Months)

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Haemophilia A without inhibitors
    Investigated Drugs:
    • Emicizumab
    Austria Belgium France Germany Italy Spain

  • Study on Ravulizumab for Patients with Thrombotic Microangiopathy After Stem Cell Transplant

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Thrombotic microangiopathy
    Investigated Drugs:
    • Ravulizumab
    Belgium France Germany Greece Italy The Netherlands +3

  • Study of Tislelizumab, Pamiparib, and Ociperlimab in Patients with Advanced Solid Tumors and Blood Cancers

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Haematological malignancy
    • Neoplasm malignant
    Investigated Drugs:
    • Ociperlimab
    • Pamiparib
    • Tislelizumab
    France Italy Poland

  • Study on the Safety of Tafasitamab and Lenalidomide for Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    • Diffuse large B-cell lymphoma
    Investigated Drugs:
    • Tafasitamab
    • Lenalidomide
    Austria Czechia Italy Poland Spain

  • Safety Study of Damoctocog Alfa Pegol for Children Aged 7 to 11 with Severe Hemophilia A

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Factor VIII deficiency
    Investigated Drugs:
    • Damoctocog Alfa Pegol
    Italy Norway

  • Study on the Safety and Effectiveness of Adding Hydroxycarbamide to Standard Treatment with Cytarabine and Daunorubicin for Adults with Newly Diagnosed Acute Myeloid Leukemia

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    • Acute myeloid leukaemia
    Investigated Drugs:
    • Hydroxycarbamide
    • Cytarabine
    • Daunorubicin
    Sweden
Previous Page
1 … 65 66 67 68 69 … 89
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!